Diisopropylethylamine → 4-[7-[1-(cyclopentylacetyl)piperidin-4-yl]-3-methyl-3,4-dihydroisoquinolin-2(1H)-yl]-6-(4-methylpiperazin-1-yl)pyrimidin-2-amine
Reaction equation
Cl.[CH3:2][N:3]1[CH2:8][CH2:7][N:6]([C:9]2[CH:14]=[C:13]([N:15]3[CH:24]([CH3:25])[CH2:23][C:22]4[C:17](=[CH:18][C:19]([CH:26]5[CH2:31][CH2:30][NH:29][CH2:28][CH2:27]5)=[CH:20][CH:21]=4)[CH2:16]3)[N:12]=[C:11]([NH2:32])[N:10]=2)[CH2:5][CH2:4]1.C(N(CC)C(C)C)(C)C.[CH:42]1([CH2:47][C:48](Cl)=[O:49])[CH2:46][CH2:45][CH2:44][CH2:43]1>C(#N)C.CO>[CH:42]1([CH2:47][C:48]([N:29]2[CH2:28][CH2:27][CH:26]([C:19]3[CH:18]=[C:17]4[C:22]([CH2:23][CH:24]([CH3:25])[N:15]([C:13]5[CH:14]=[C:9]([N:6]6[CH2:7][CH2:8][N:3]([CH3:2])[CH2:4][CH2:5]6)[N:10]=[C:11]([NH2:32])[N:12]=5)[CH2:16]4)=[CH:21][CH:20]=3)[CH2:31][CH2:30]2)=[O:49])[CH2:46][CH2:45][CH2:44][CH2:43]1Participants
6
Reactant 3
Product 1
Reagents, catalysts & solvents 2
Procedure
4-(4-Methylpiperazin-1-yl)-6-(3-methyl-7-piperidin-4-yl-3,4-dihydroisoquinolin-2(1H)-yl)pyrimidin-2-amine HCl salt (21.1 mg) in acetonitrile (0.50 mL) was treated with N,N-diisopropylethylamine (0.070 mL, 0.40 mmol). To the solution was added cyclopentylacetyl chloride (10.0 mg). The mixture was stirred at r.t. for 2 h. The mixture was diluted with methanol, and purified by RP-HPLC (pH=10) to afford the desired product. LCMS (M+H)+: m/z=532.3.
Workup
- custompurified by RP-HPLC (pH=10)
Sources & evidence
- ORD record
- ord-f2936b95c8394476a1b3e95f4d0d3dce
- Source dataset
- uspto-grants-2013_05
- Patent number
- US08436008B2
Reaction notes
Loading…